콘텐츠로 건너뛰기

금융 뉴스 허브

실시간 글로벌 금융 시장 뉴스 · 분석 · 인사이트

📈 강세장 분위기

BREAKING주요 뉴스

주식/증권 📈 긍정
08/24 14:52
Morgan Stanley Gains 45.1% in a Year: Should You Buy MS Stock Now?

MS outpaces peers with a 45.1% share price gain, but trading cyclicality, rising expenses and a premium valuation could limit further upside.

Yahoo Finance
주식/증권 📈 긍정
08/24 14:51
NET Power surges after securing rights to acquire 123 MW of generation capacity

Seeking Alpha - Market News
주식/증권 📈 긍정
08/24 14:47
Earnings Season Is Almost Done. A Big Report Is Coming Up

Investor attention will undoubtedly focus this week on the latest quarterly results from Nvidia.

Yahoo Finance
주식/증권 📈 긍정
08/24 14:37
Welltower, Realty Income lead S&P Real Estate stocks on growth

Seeking Alpha - Market News
주식/증권 📈 긍정
08/24 14:29
Focus on Mid-Week: NVIDIA Earnings, PCE Report

NVIDIA is expected to generate +99% earnings growth and PCE looks to remain high at +3.6%.

Yahoo Finance
주식/증권 📈 긍정
08/24 14:27
Capricor rises as FDA extends Deramiocel action date

Seeking Alpha - Market News
주식/증권 📈 긍정
08/24 14:27
Estee Lauder Stock Jumped On A Bigger Margin Promise

The beauty group's repricing rests on a profit plan it controls, while the low end of its new sales guidance is no faster than the year just ended.

Yahoo Finance
주식/증권 📈 긍정
08/24 14:17
Domino's Stock Slips 15% in 6 Months: Should You Buy, Hold or Sell?

DPZ's 15.3% six-month slide reflects weak ticket trends and margin pressure, but order growth, loyalty gains and a discounted valuation support a hold.

Yahoo Finance
주식/증권 📈 긍정
08/24 14:14
Nvidia Stock: Why It May Be Raising Prices 15% and Funding AI Startups

Nvidia stock is reacting to news of the company making major AI investments and a potential price hike.

Yahoo Finance
주식/증권 📈 긍정 🔴 매우 중요
08/24 14:10
Steel Stocks Jump as U.S.-Canada Tariff Fight Escalates

Steel Dynamics, Nucor, and Cleveland-Cliffs shares rise as escalating U.S.-Canada trade tensions put steel tariffs back in focus.

Yahoo Finance
주식/증권 📈 긍정
08/24 14:09
SYRE Rallies 44.9% in 3 Months. Can Clinical Catalysts Sustain It?

Spyre's 2026 clinical catalysts and positive ulcerative colitis data fuel momentum, but its lofty valuation raises the stakes for upcoming readouts.

Yahoo Finance